BOD L19 - Tumour Immunotherapy Flashcards

To understand what cancer immunotherapy is. To identify the main types and mechanisms of immunotherapy. Questions: - Can immune stimulators combat cancer? - Which forms of immunotherapy can be used? - Is vaccination effective against established tumours? - Can anti-tumour responses be generated in vitro? - Can in vitro responses translate into in vivo effects? - What barriers are there to develop effective IT?

You may prefer our related Brainscape-certified flashcards:
1
Q

Why is cancer immunotherapy difficult?

A

Cancers are ‘self’ and immune system is educated to not react against self antigen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Briefly how does a cancer vaccine work?

A

Tumour cell broken up to release antigens.

In body, APCs able to recruit T cells to recognise antigens.

Then CTLs able to recognise & destroy tumour cells, and Th cells able to educate other T/B cells for AB/ADCC/cytokine attack.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How was the first cancer therapies discovered?

A

Cancer patients were given fungal and bacterial infections, and it was noted some tumours went into regression.

First cancer therapies were bacterial and fungal components. BCG bacterial protein first used as adjuvant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How can immune cell phenotypes present in cancers be a prognosis predictor?

A

High levels of CD8+ and CD4+Th1 T cells were linked with positive prognosis.

Poor linked with Th2, Th17 and Treg.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the two different categories of immunotherapy?
The subcategories, with examples?

A

Active and passive.

Either of these can be non-specific or specific.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the two examples of passive immunotherapy used?

A

T cell therapy
Tumour-antigen specific T cells can be removed from patient and expanded in vitro. Then transfered back into patient.

Monoclonal antibody therapy
Antibodies against tumour antigen given to patient, which kill cancer cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are four strategies of cancer immunotherapy?

A

Cancer vaccines. T cell therapy. Monoclonal antibodies. Oncolytic viruses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What cytokine has seen good success as a therapy for cancer?

A

IL-2 therapy in kidney cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give an example of passive, non-specific immunotherapy

A

BCG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give an example of active, specific immunotherapy

A

Vaccine (preventative/therapeutic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Give an example of passive, non-specific immunotherapy

A

LAK (lymphokine activated killer) cells, cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give an example of a passive, specific immunotherapy

A

antibodies, T cell therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the four cancer immunotherapy strategies?

A

Vaccines,
antibodies,
ex-vivo activated T-cells or NKs.
oncolytic viruses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the four ways antibodies can kill target cells?

A

CDC, ADCC, direct apoptosis, conjugated to toxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What molecule competetively binds B7 during T cell activation?

A

CTLA-4.

Checkpoint inhibitor in T cells, downregulate immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are two good targets for inducing immune responses to tumours?

A

CTLA4, blocking this causes tumour rejection.

Tumours can up-reg CTLA4 and CTLA4 expressing T cells (Tregs) to dampen the immune response.

PD-1 also blocks CTL tumour cell death. Good target to inhibit to cause CTL-mediated death